Alfonso Martinez
Research Associate, Formulation Discovery
Meet the rest of our
see all team members
Jodie Morrison
Chief Executive Office and Director, Q32 Bio Inc.
Andrew Ashe, J.D.
President, Chief Operating Officer and General Counsel
Krishna Yeshwant, M.D.
Managing Partner, GV
Troy Lister, Ph.D.
Chief Scientific Officer
Lonnel Coats
Chief Executive Officer and Director, Lexicon Pharmaceuticals
Michael MacLean
Chief Financial Officer and Chief Business Officer, Avidity Biosciences
Jason Politi
Chief Technical Operations Officer
Daniel J. Rader, M.D.
Chair, Department of Genetics, University of Pennsylvania
Nia Tatsis, Ph.D.
Executive Vice President and Chief Regulatory and Quality Officer, Vertex Pharmaceuticals
Eugene Braunwald, M.D.
Distinguished Hersey Professor of Medicine at Harvard Medical School
Sheila Mikhail, J.D.
Co-Founder and Former Chief Executive Officer, AskBio; Co-Founder and Chief Executive Officer, Jurata Thin Film
Andrew Geall, Ph.D.
Co-Founder and Chief Development Officer, Replicate Bioscience
Fred Fiedorek, M.D.
Chief Medical Officer
J. Keith Joung, M.D., Ph.D.
Robert B. Colvin, M.D. Endowed Chair in Pathology and Pathologist, Massachusetts General Hospital; Professor of Pathology, Harvard Medical School
Allison Dorval
Chief Financial Officer
Bo Cumbo
President and Chief Executive Officer, Solid Biosciences
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Joan Nickerson
Chief Administrative Officer
Barry Ticho, M.D., Ph.D.
Chief Medical Officer, Stoke Therapeutics
Burt Adelman, M.D.
Chairman of the Board; former EVP and Chief Medical Officer, Dyax
Issi Rozen
Venture Partner, GV
Kiran Musunuru, M.D., Ph.D.
Professor of Cardiovascular Medicine and Genetics, Perelman School of Medicine at the University of Pennsylvania
Leslie Stolz, Ph.D.
Senior Vice President, Regulatory Affairs
Anthony Philippakis, M.D., Ph.D.
Chief Data Officer, Broad Institute of MIT and Harvard
